PT-141 10mg
PT-141 supports sexual desire and arousal in women and men, acting on the brain rather than on blood flow. It is a fit for clients whose low libido is not explained by hormones alone, or who want a short-acting option before intimacy.
- Product Usage: Not for Human or Veterinary Use
$60.00
- Product Usage: Not for Human or Veterinary Use
Pure Health Peptides products are supplied to qualified research professionals and institutional users for in vitro laboratory research only. KYC verification is required prior to order fulfillment, and we reserve the right to refuse orders that do not meet buyer qualification criteria. These products are not drugs, foods, cosmetics, diagnostic products, or dietary supplements, have not been evaluated by the FDA, and are not intended for human or animal use. Any such use is prohibited and may violate federal, state, or local law. By purchasing, the buyer represents and warrants that the product will be used solely for in vitro research. The buyer agrees to indemnify, defend, and hold harmless Pure Health Peptides, its officers, employees, and agents from and against any and all claims, damages, losses, liabilities, costs, and expenses (including reasonable attorneys fees) arising out of or relating to the buyer’s use, handling, storage, or disposition of the product in any manner inconsistent with its research-use-only designation or applicable law.
PT-141 supports sexual desire and arousal in women and men, acting on the brain rather than on blood flow. It is a fit for clients whose low libido is not explained by hormones alone, or who want a short-acting option before intimacy.
PT-141, also called bremelanotide, is a melanocortin receptor agonist derived from melanocyte-stimulating hormone. It works through central pathways tied to desire, rather than as a vasodilator like sildenafil. It is given as a subcutaneous injection, timed before sexual activity.
Published research has examined PT-141 for hypoactive sexual desire and arousal. Clients often use it when interest is low despite normal labs, or when a blood-flow drug has not addressed desire. It is not a hormone and it does not replace evaluation of relationship, mood, or medication causes.
A typical dose is clinician-directed and used as needed, not as a daily drug. Response is individual. Early effects can include flushing, nausea, or a temporary rise in blood pressure. It is not a substitute for evaluation of uncontrolled hypertension or cardiovascular disease.
